人瑞人才(06919.HK)挫近14%創年內新低 市前有折讓9%大手上板
人瑞人才(06919.HK)今早市前有一宗200萬股以每股33.08元(較上周五收市價折讓約9%)非自動對盤上板,涉資6,616萬元。該股今天曾低見31.25元,為去年12月31日以來最低,現造31.4元,續挫13.6%,成交增至366萬股,涉資1.21億元。
人瑞人才是內地快速增長的人力資源解決方案先驅。股份去年12月13日以每股26.6元來港上市。掛牌首兩天盤中股價曾失守上市價低見25.8元獲承接,之後反覆上升,今年2月中旬曾高見55.2元新高遇阻回落。該公司今年3月公布2019年全年虧損按年擴近4.7倍至7.8億人民幣,營收按年升近42%至22.88億人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.